Здоровье
FDA не обнаружило нарушений на испытательных площадках в отношении вакцины Pfizer против болезни Лайма
A U.S. health regulator found no violations at clinical centres run by Care Access for Pfizer and French partner Valneva in a trial of a
Более 7 миллионов американцев получили обновленные вакцины от COVID
According to the US Department of Health and Human Services, more than 7 million Americans have received the updated COVID-19 vaccines, despite reports that some
Индия оправдала фирму по производству сиропа от кашля, связанную со смертью узбеков
The northern Indian state of Uttar Pradesh has authorised the resumption of most of the production at a plant owned by Marion Biotech that made
Суд одобрил реструктуризацию Mallinckrodt и сокращение возмещения расходов на опиоиды на $1 млрд.
Pharmaceutical company Mallinckrodt has received court approval for a bankruptcy plan that reduces by $1 billion the amount it owes to victims of the opioid
Производитель лекарств GSK урегулировал еще один иск в Калифорнии по поводу лекарства от изжоги Zantac
GSK on Wednesday said it would confidentially settle another lawsuit in California alleging that its discontinued heartburn drug Zantac caused cancer, as the British drugmaker
Alnylam отказывается расширять использование лекарств от сердечно-сосудистых заболеваний в США
Alnylam Pharmaceuticals said it will not expand the use of its drug to treat a potentially fatal heart condition in the U.S. after the Food
Число работодателей в США, платящих за лекарства для похудения, может почти удвоиться в 2024 году
The number of U.S. employers paying for obesity drugs, including Novo Nordisk’s Wegovy, which belongs to the GLP-1 class of drugs, could nearly double next
Препарат AnaptysBio для лечения кожных заболеваний достиг основной цели исследования на поздней стадии
AnaptysBio said its experimental drug to treat one of the rare skin diseases has achieved the primary endpoint of a late-stage study. The drug helped
Гейтс пожертвовал $40 миллионов на расширение доступа к мРНК-вакцинам в Африке
The Bill & Melinda Gates Foundation will donate $40 million to a Belgian biotech company and two leading African vaccine manufacturers in a bid to
Bristol-Myers Squibb приобретет Mirati за $5,8 млрд.
Bristol-Myers Squibb announced it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can